The Next Big Thing In Biotech: FDA Decisions
Dec 14, 2012 | 5:30 AM EST - 

Adam Feuerstein, Sr. Columnist for TheStreet, says three big FDA drug approval decisions are the next big things to watch in biotech.

Columnist Conversations

You really get the sense from recent comments from Fed officials, such as Yellen and Fischer, that a good data...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.